![](/img/cover-not-exists.png)
Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived
Alessandro Corso, Marzia Varettoni, Silvia Mangiacavalli, Patrizia Zappasodi, Gian Matteo Pica, Alessandra Algarotti, Cristiana Pascutto, Mario LazzarinoVolume:
83
Year:
2009
Language:
english
Pages:
6
DOI:
10.1111/j.1600-0609.2009.01295.x
File:
PDF, 97 KB
english, 2009